Yoga for Non-Small Cell Lung Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial studies how well dyadic yoga intervention works in improving physical performance and quality of life in patients with stage I-IV non-small cell lung or esophageal cancer undergoing radiotherapy and their caregivers. Dyadic yoga intervention may help to improve physical function, fatigue, sleep difficulties, depressive symptoms, and overall quality of life for patients with non-small cell lung cancer and/or their caregivers.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is yoga safe for people with cancer, including those with lung cancer?
How is the Dyadic Yoga Intervention treatment different from other treatments for non-small cell lung cancer?
The Dyadic Yoga Intervention is unique because it involves partner-supported yoga, which aims to improve both psychosocial and physical function, enhancing quality of life for lung cancer patients. Unlike traditional treatments that focus on directly targeting cancer cells, this approach emphasizes mind-body practices to support overall well-being and is delivered in a supportive, couple-based format.12467
What data supports the effectiveness of the treatment Dyadic Yoga Intervention for Non-Small Cell Lung Cancer?
Who Is on the Research Team?
Kathrin Milbury, MA,PHD
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
This trial is for patients with stage I-IV non-small cell lung or esophageal cancer who are about to undergo at least 3 weeks of thoracic radiotherapy. They must be able to perform daily activities (ECOG <=2), speak English, and consent. Caregivers can join optionally if they're adults, speak English, and give consent. People practicing mind-body techniques in the past year or with brain metastases cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo dyadic yoga intervention or dyadic education program for up to 15 sessions, each lasting 60 minutes
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Dyadic Yoga Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator